Exploring the Role of Epigenetic Modifications in Cancer Development and Progression

Thesis Abstract

Abstract
Cancer remains a significant global health challenge, with a complex interplay of genetic and epigenetic factors contributing to its development and progression. This thesis aims to explore the role of epigenetic modifications, specifically DNA methylation, histone modifications, and non-coding RNAs, in cancer pathogenesis. The study is structured around a comprehensive literature review, research methodology, discussion of findings, and conclusion. The introductory chapter provides a background to the study, highlighting the importance of understanding epigenetic alterations in cancer biology. The problem statement underscores the need to elucidate the mechanisms by which epigenetic modifications influence cancer initiation, progression, and therapeutic response. The objectives of the study focus on investigating specific epigenetic changes associated with different cancer types and their potential as diagnostic and therapeutic targets. Limitations of the study are acknowledged, including the complexity of epigenetic interactions and the challenges in translating research findings into clinical applications. The scope of the study encompasses a wide range of cancer types and epigenetic markers, aiming to provide a comprehensive overview of the field. The significance of the study lies in its potential to inform precision medicine approaches and improve cancer treatment outcomes. The literature review chapter synthesizes existing knowledge on epigenetic modifications in cancer, covering topics such as DNA methylation patterns in tumor suppressor genes, histone modifications in chromatin remodeling, and the role of non-coding RNAs in gene regulation. Key findings from previous studies are critically analyzed to identify gaps in current understanding and guide the research methodology. The research methodology chapter outlines the experimental approach, including sample collection, epigenetic profiling techniques, data analysis methods, and statistical validation. The study design incorporates both in vitro and in vivo models to investigate the functional consequences of specific epigenetic alterations on cancer cell behavior and tumor growth. The discussion of findings chapter presents the results of epigenetic profiling in various cancer cell lines and patient samples, highlighting significant changes in DNA methylation patterns, histone modifications, and non-coding RNA expression. The implications of these findings for cancer biology are discussed in the context of tumor heterogeneity, therapy resistance, and potential biomarker discovery. In conclusion, this thesis contributes to the growing body of knowledge on the role of epigenetic modifications in cancer development and progression. The findings underscore the complexity of epigenetic regulation in cancer and the need for targeted therapies that exploit these alterations. Future research directions are proposed to further elucidate the functional significance of specific epigenetic changes and their clinical utility in cancer management.